Advertisement
Table 3 Estimated unadjusted and adjusted odds ratios (OR) with 95 percent confident intervals for the risk of death obtained from the dynamic logistic regression model and based on 1482 individuals in the CDM group alive after the first year of the follow-up
| Unadjusted OR | 95% CI | Adjusted OR | 95% CI | P-value | |
|---|---|---|---|---|---|
| Adherence history: | |||||
| poor at least once vs optimal | 2.14 | (1.45, 3.14) | 2.18 | (1.47, 3.22) | <0.001 |
| non-response at least once vs optimal | 2.16 | (1.29, 3.52) | 2.09 | (1.22, 3.40) | <0.001 |
| missing at least once vs optimal | 3.46 | (2.07, 5.54) | 3.65 | (2.15, 5.92) | 0.005 |
| Pre-ART WHO disease stage | |||||
| stage 2 | 1(ref) | 1(ref) | 0.51 | ||
| stage 3 | 1.67 | (0.99, 3.03) | 1.39 | (0.82, 2.55) | |
| stage 4 | 1.61 | (0.88, 3.08) | 1.28 | (0.68, 2.48) | |
| Pre ART CD4 cell count | |||||
| 0-49 | 3.61 | (1.88, 7.85) | 3.43 | (1.74, 7.62) | |
| 50-99 | 2.75 | (1.36, 6.14) | 2.62 | (1.28, 5.90) | |
| 100-149 | 2.49 | (1.20, 5.63) | 2.45 | (1.18, 5.57) | |
| 150-199 | 1(ref) | 1(ref) | 0.01 | ||
| Pre-ART Body mass index | |||||
| <20 | 1.63 | (1.12, 2.38) | 1.33 | (0.90, 1.96) | |
| 20-27 | 1(ref) | 1(ref) | 0.35 | ||
| >27 | 0.98 | (0.43, 1.93) | 1.07 | (0.46,2.15) | |
| Age at ART initiation groups | |||||
| 18-35 | 1(ref) | 1(ref) | 0.07 | ||
| 35-50 | 0.72 | (0.49, 1.05) | 0.83 | (0.56, 1.24) | |
| 50+ | 1.45 | (0.74, 2.63) | 1.74 | (0.87, 3.21) | |
| Sex | |||||
| Female vs Male | 0.62 | (0.43, 0.90) | 0.72 | (0.49, 1.06) | 0.10 |
| Time since ART initiation in years | |||||
| ≤2 | 1(ref) | 1(ref) | 0.13 | ||
| 2-3 | 1.65 | (0.98, 2.84) | 1.66 | (0.98, 2.86) | |
| 3-4 | 1.10 | (0.61, 1.99) | 1.10 | (0.61, 1.98) | |
| 4-5 | 1.64 | (0.96, 2.86) | 1.56 | (0.90, 2.74) | |
| >5 | 0.91 | (0.38, 1.96) | 0.80 | (0.33, 1.73) |
